OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

Oh ffs tabby another wing and a prayer job you got in at a much higher price.

Stick to mks.

Dil what are you like on logarithms or compound multiplication?not too good I would presumemy combined accounts are showing a double digit profit at this moment in time on OXBare you forgetting I am invincible!with you posting on the MDX thread along with the nobssuggest you are trying to provoke a situation

Im too happy mate!!! Family retired on BLNX alonethen SER came along.whoooooooshplus another on the wayIll tell you about it later. But I am still capable of telling a few to fcuk off!! So dont get cheeky..

Dilwhat are you one day on three months off?listenafter speaking with my usual crew I have a hunch that there is significant interest in this stock No ramp intended

Keep an eye on the trading patternsOXB are not very good at keeping secretsdont say I havent pointed you in the right directionJKDI am also telling you now OK?no silly post after the event please

Watch this space

Continued one-sided trading.what gives?

Same again today!

Same again today!

Very interesting on the ITV websiteTrovax is back in voguegood story for OXB...

http://www.itv.com/meridian-west/new-lung-cancer-medicine79290/

It's true there was a decent rise mid-2011 (July Sun?) but it's been falling ever since.

OXB just never seems to keep hold of its rises, so I guess it mainly MM's having a laugh.
At these prices you'd expect folk to be falling over themselves, but I made a nice turn recently and sold half - should have sold them all.
+ Still have large holding from earlier and higher, say average 20p but reported deals will transform this foal into a thoroughbred winner (er, I hope!).

However, there is not much evidence others think the same...

The MMs are certainly at it to-day - 4 mil buys 1 mil sells and down 25%.

I don't understand why there's been a great fall, I thought the clinical update was very positive - to the extent if they'd risen to 6p I might be a Buyer - but clearly the Market as a whole thinks this (result?) is Negative - were they expecting a OTC pill?
- oh no, I get it -Happy Pills, that's what they should have been making - and we've yet to hear if their "new facility" has be finished.

My comment yesterday, was premature, eh? "..However, there is not much evidence others think the same..."

So, who were part of tabasco's 'crew?'

Did try and tell him that drug comps were a waste of time but of course he knew better, hey ho.

Anyone understand why the recent News has been treated as "bad"?
EDIT(10Feb2012)- A.Wood steps aside as FD; pity. +I bought some more last month as near cash-value approaches.
EDIT(15Feb2012)-Oh deary, Dir add a few to his 300,000shares (£9K)DYOR. Not exactly a big invt?
EDIT(17April2012) - Big rise on PhI/II PD results, but these were expected, weren't they? Back soon to 3p I guess.
EDIT,(6Jn2012)- 3p04 now just, below latest buys, to be expected with the Greeks rioting again, soon. I'm hopeful it will rise=double figures like 60p before we're Out.

Sp lowest ever, director buying, large shareholder increases stake over 15per cent. Prob get bought out at 10p

Another winner Tabby ... ffs u can't half pick em.

BTW ... who you posting as now ?

Er we go

more stakebuilding?

back to what i paid for mine !!!
what to do now is the question.....

Interim Management Statement


PIPELINE HIGHLIGHTS
LentiVector® platform
Ocular programmes (gene-based therapies targeting vision loss): partnered with Sanofi
· First RetinoStat® Phase I results (n=6) presented at 2012 ARVO Annual Meeting on Monday, 7 May 2012 indicate sustained, dose-related protein expression in the eye
· Early data show a clear dose response1, with the 10-fold escalation to dose level 2 (n=3) yielding a similar increase in average protein expression

ProSavin® (gene-based therapy for Parkinson's disease): development update
· Phase I/II study successfully met primary endpoints: ProSavin® is safe, well-tolerated and mediates long-term improvement of motor function, announced in April 2012
· Summary of data to be presented at the ASGCT 15th Annual Meeting on Thursday, 17 May 2012

5T4 tumour antigen platform
TroVax® (therapeutic cancer vaccine): publication in Lung Cancer
· Article entitled "Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma" published in Lung Cancer in April 2012 which underpins the upcoming sponsored Phase II study for TroVax® in mesothelioma